CN Patent
CN101031303A — 包含zd6474的药物组合物
Assigned to Genzyme Corp · Expires 2007-09-05 · 19y expired
What this patent protects
本发明提供了一种包括ZD6474或其可药用盐、脆性稀释剂和几乎不可溶并具有可延展压缩性的第二稀释剂的药物组合物。
USPTO Abstract
本发明提供了一种包括ZD6474或其可药用盐、脆性稀释剂和几乎不可溶并具有可延展压缩性的第二稀释剂的药物组合物。
Drugs covered by this patent
- Caprelsa (VANDETANIB) · Sanofi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.